DRAP Warns Against Life-Threatening Fake Medicines
Notably, the Drug Regulatory Authority of Pakistan (DRAP) has issued rapid alerts over five batches of fake medicines detected in Karachi, warning that their employ could pose serious health risks.
Notably, the Drug Regulatory Authority of Pakistan (DRAP) has issued rapid alerts over five batches of fake medicines detected in Karachi, warning that their employ could pose serious health risks.
Article outline
- What happened
- Official response
- Why it matters
- The bottom line
Key points
- According to DRAP, the affected products include Augmentin tablets, Velosef capsules, Nasomet nasal spray, No-Spa Forte 80mg tablets and Mucaine syrup.
- The Drug Testing Laboratory in Karachi declared samples from all five batches counterfeit.
- These medicines are applied to treat conditions including bacterial infections, allergies, muscle spasms, and gastric irritation.
- While their quality, safety, and effectiveness remain unknown, it continued that the raw materials employed in the sampled medicines could not be verified.
- The authority remarked the products were manufactured illegally and supplied to the market under the brand names of national and multinational pharmaceutical businesses.
For context, the Drug Testing Laboratory in Karachi declared samples from all five batches counterfeit. Punjab Recalls 2 Drugs Over Safety Reservations.
In practice, the authority remarked the products were manufactured illegally and supplied to the market under the brand names of national and multinational pharmaceutical businesses.
DRAP cautioned that using these fake products could be life-threatening and directed provincial drug control authorities and field teams to seize the affected batches from the market. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover. Follow on Google News Join WhatsApp. See more ProPakistani stories in Google Search and Top Stories.
In short, DRAP Warns Against Life is the central thread here, and readers can expect follow-up reporting as the picture becomes clearer.




